SCHEMBL2786294

SCHEMBL2786294

Nc1ccc2cc3c(N)cccc3cc2c1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 11/20 0.65
CYP3A4 P08684 6/20 0.65
HSD17B10 Q99714 6/20 0.65
TDP1 Q9NUW8 3/20 0.65
CASP1 P29466 3/20 0.65
HIF1A Q16665 2/20 0.65
ALOX15 P16050 1/20 0.65
CASP7 P55210 1/20 0.65
HBB P68871 1/20 0.65
PLAU P00749 3/20 0.50
F2 P00734 2/20 0.46
PLG P00747 1/20 0.46
PLAT P00750 1/20 0.46
KLK1 P06870 1/20 0.46
PRSS1 P07477 1/20 0.46
CTDSP1 Q9GZU7 1/20 0.46
HPGD P15428 3/20 0.45
TSHR P16473 3/20 0.45
KEAP1 Q14145 1/20 0.45
KDM4E B2RXH2 6/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14742519 1.00 ALDH1A1 (0.65) ALDH1A1CYP3A4HSD17B10TDP1CASP1
SCHEMBL30062964 1.00 ALDH1A1 (0.65) ALDH1A1CYP3A4HSD17B10TDP1CASP1
SCHEMBL5008737 0.88 ALDH1A1 (0.54) ALDH1A1CYP3A4HSD17B10TDP1CASP1
SCHEMBL5012440 0.88 ALDH1A1 (0.54) ALDH1A1CYP3A4HSD17B10TDP1CASP1
SCHEMBL4924420 0.87 ALDH1A1 (0.58) ALDH1A1CYP3A4HSD17B10TDP1CASP1
SCHEMBL5008832 0.87 ALDH1A1 (0.58) ALDH1A1CYP3A4HSD17B10TDP1CASP1
SCHEMBL28465029 0.87 ALDH1A1 (0.58) ALDH1A1CYP3A4HSD17B10TDP1CASP1
SCHEMBL22497391 0.87 ALDH1A1 (0.58) ALDH1A1CYP3A4HSD17B10TDP1CASP1
SCHEMBL5008632 0.87 ALDH1A1 (0.58) ALDH1A1CYP3A4HSD17B10TDP1CASP1
SCHEMBL29391698 0.87 ALDH1A1 (0.58) ALDH1A1CYP3A4HSD17B10TDP1CASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115463548-B Pollution-resistant reverse osmosis membrane and preparation method thereof 恩泰环保科技(常州)有限公司 2024-04-19 CN claimed
CN-115463548-A Pollution-resistant reverse osmosis membrane and preparation method thereof 恩泰环保科技(常州)有限公司 2022-12-13 CN claimed
CN-115463548-B Pollution-resistant reverse osmosis membrane and preparation method thereof 恩泰环保科技(常州)有限公司 2024-04-19 CN disclosed
CN-115463548-A Pollution-resistant reverse osmosis membrane and preparation method thereof 恩泰环保科技(常州)有限公司 2022-12-13 CN disclosed
US-9676907-B2 Methods and systems of graft polymerization on a functionalized substrate ASPEN RESEARCH CORPORATION (US) 2017-06-13 US disclosed
US-20160168331-A1 METHODS AND SYSTEMS OF GRAFT POLYMERIZATION ON A FUNCTIONALIZED SUBSTRATE JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT 2016-06-16 US disclosed
US-9267009-B2 Methods and systems of graft polymerization on a functionalized substrate ASPEN RESEARCH CORPORATION (US) 2016-02-23 US disclosed
US-20140296366-A1 METHODS AND SYSTEMS OF GRAFT POLYMERIZATION ON A FUNCTIONALIZED SUBSTRATE ASPEN RESEARCH CORPORATION (US) 2014-10-02 US disclosed
US-20140296339-A1 SUBSTITUTED PHENETHYLAMINES WITH SEROTONINERGIC AND/OR NOREPINEPHRINERGIC ACTIVITY ACADIA PHARMACEUTICALS INC. 2014-10-02 US disclosed
US-8734917-B2 Liquid crystal display device JAPAN DISPLAY INC. (JP) 2014-05-27 US disclosed
US-8734917-B2 Liquid crystal display device JAPAN DISPLAY INC. (JP) 2014-05-27 US disclosed
US-20130085237-A1 Fluorinated Diamine and Polymer Formed Therefrom CENTRAL GLASS COMPANY, LIMITED (JP) 2013-04-04 US disclosed
WO-2013033610-A1 METHODS AND SYSTEMS OF GRAFT POLYMERIZATION ON A FUNCTIONALIZED SUBSTRATE ASPEN RESEARCH CORPORATION (US) 2013-03-07 WO disclosed
US-20110221984-A1 LIQUID CRYSTAL DISPLAY DEVICE HITACHI DISPLAYS, LTD. 2011-09-15 US disclosed
US-20110221984-A1 LIQUID CRYSTAL DISPLAY DEVICE HITACHI DISPLAYS, LTD. 2011-09-15 US disclosed
US-20110080547-A1 LIQUID CRYSTAL DISPLAY DEVICE JAPAN DISPLAY EAST INC. (JP) 2011-04-07 US disclosed
US-20110080547-A1 LIQUID CRYSTAL DISPLAY DEVICE JAPAN DISPLAY EAST INC. (JP) 2011-04-07 US disclosed
US-20100029895-A1 Fluorinated Diamine and Polymer Formed Therefrom CENTRAL GLASS COMPANY, LIMITED (JP) 2010-02-04 US disclosed
US-6808766-B1 ALIGNMENT AGENT COMPRISING POLYURETHANE OR POLYUREA, USED IN ALIGNMENT OF LIQUID CRYSTAL MOLECULES THAT FORM LIQUID CRYSTAL ALIGNMENT FILM BY IRRADIATING THIN ALIGNMENT FILM FORMED ON SUBSTRATE WITH POLARIZED LIGHT OR ELECTRON RAYS NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2004-10-26 US disclosed
EP-1111442-A1 TREATING AGENT FOR LIQUID CRYSTAL ALIGNMENT LAYER AND LIQUID CRYSTAL DEVICE USING THE SAME, AND METHOD FOR ALIGNMENT OF LIQUID CRYSTAL Nissan Chemical Industries, Ltd. (JP) 2001-06-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140296339-A1 SUBSTITUTED PHENETHYLAMINES WITH SEROTONINERGIC AND/OR NOREPINEPHRINERGIC ACTIVITY SLC6A4, HTR4, GPR34 ALDH1A1 3075/4885CYP3A4 278/4885HSD17B10 3677/4885
US-20100029895-A1 Fluorinated Diamine and Polymer Formed Therefrom AFF2, AFF1, AFF4 ALDH1A1 931/4885CYP3A4 3797/4885HSD17B10 3598/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.